These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9126061)

  • 1. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease progression. PET and clinical observations.
    Andrews TC; Weeks RA; Turjanski N; Gunn RN; Watkins LH; Sahakian B; Hodges JR; Rosser AE; Wood NW; Brooks DJ
    Brain; 1999 Dec; 122 ( Pt 12)():2353-63. PubMed ID: 10581228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.
    Bäckman L; Robins-Wahlin TB; Lundin A; Ginovart N; Farde L
    Brain; 1997 Dec; 120 ( Pt 12)():2207-17. PubMed ID: 9448576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
    Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
    Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.
    Pavese N; Andrews TC; Brooks DJ; Ho AK; Rosser AE; Barker RA; Robbins TW; Sahakian BJ; Dunnett SB; Piccini P
    Brain; 2003 May; 126(Pt 5):1127-35. PubMed ID: 12690052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging.
    Ishiwata K; Ogi N; Hayakawa N; Oda K; Nagaoka T; Toyama H; Suzuki F; Endo K; Tanaka A; Senda M
    Ann Nucl Med; 2002 Nov; 16(7):467-75. PubMed ID: 12508837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
    Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
    Rosa-Neto P; Doudet DJ; Cumming P
    Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
    Besret L; Page KJ; Dunnett SB
    Brain Res; 2000 Jan; 853(1):125-35. PubMed ID: 10627316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
    Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.
    Tsukada H; Kreuter J; Maggos CE; Unterwald EM; Kakiuchi T; Nishiyama S; Futatsubashi M; Kreek MJ
    J Neurosci; 1996 Dec; 16(23):7670-7. PubMed ID: 8922423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
    Farde L; Halldin C; Stone-Elander S; Sedvall G
    Psychopharmacology (Berl); 1987; 92(3):278-84. PubMed ID: 2957716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.